Cargando…
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial
BACKGROUND: In recent years, an increasing number of anticancer drugs have been approved based on the results of a single-arm trial (SAT). The magnitude of the objective response rate (ORR) in SATs is important for regulatory decisions, but there has been no clear guidance specifying the degree of O...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922846/ https://www.ncbi.nlm.nih.gov/pubmed/35291959 http://dx.doi.org/10.1186/s12885-022-09383-w |